Inventor · disambiguated record
Michael J. Breslin
Also filed as: BRESLIN MICHAEL J
20 granted patents·8 pending applications·307 citations·filing 1994–2024
94Inventor score
Files withMERCK & CO INC9BRESLIN MICHAEL J7MERCK SHARP & DOHME LLC6MERCK SHARP & DOHME5COX CHRISTOPHER D1
Top patents by PatentIndex Score
28 records- 0197US7951797B2Substituted diazepan orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2007·Granted May 31, 2011·59 cites·9 claims
- 0296US8710076B22,5-disubstituted piperidine orexin receptor antagonistsBRESLIN MICHAEL J·Filed 2009·Granted Apr 29, 2014·38 cites·7 claims
- 0392US8669272B22,5-disubstituted piperidine orexin receptor antagonistsBRESLIN MICHAEL J·Filed 2009·Granted Mar 11, 2014·27 cites·11 claims
- 0492US6645974B2Androgen receptor modulators and methods for use thereofMERCK & CO INC·Filed 2002·Granted Nov 11, 2003·63 cites·25 claims
- 0591US11377438B22-amino-n-heteroaryl-nicotinamides as Nav1.8 inhibitorsMERCK SHARP & DOHME·Filed 2019·Granted Jul 5, 2022·6 cites·22 claims
- 0683US8569311B2Pyridyl piperidine orexin receptor antagonistsBRESLIN MICHAEL J·Filed 2012·Granted Oct 29, 2013·6 cites·15 claims
- 0783US5585359AInhibitors of farnesyl-protein transferaseMERCK & CO INC·Filed 1994·Granted Dec 17, 1996·76 cites·27 claims
- 0882US8975261B2Aryloxmethyl cyclopropane derivatives as PDE10 inhibitorsBRESLIN MICHAEL J·Filed 2012·Granted Mar 10, 2015·4 cites·13 claims
- 0980US12331018B2Pyrrolidine orexin receptor agonistsMERCK SHARP & DOHME LLC·Filed 2020·Granted Jun 17, 2025·1 cites·6 claims
- 1080US2025084064A12-amino-n-heteroaryl-nicotinamides as nav1.8 inhibitorsMERCK SHARP & DOHME LLC·Filed 2024·Application pending·0 cites
- 1178US7153862B2αv integrin receptor antagonistsMERCK & CO INC·Filed 2003·Granted Dec 26, 2006·10 cites·5 claims
- 1272US12195445B22-amino-N-heteroaryl-nicotinamides as Nav1.8 inhibitorsMERCK SHARP & DOHME LLC·Filed 2022·Granted Jan 14, 2025·0 cites·15 claims
- 1371US8691827B2Amino tetrahydro-pyridopyrimidine PDE10 inhibitorsBRESLIN MICHAEL J·Filed 2010·Granted Apr 8, 2014·2 cites·11 claims
- 1471US8492392B2Alkoxy tetrahydro-pyridopyrimidine PDE10 inhibitorsBRESLIN MICHAEL J·Filed 2010·Granted Jul 23, 2013·2 cites·13 claims
- 1571US8349830B2Aryl aminopyridine PDE10 inhibitorsMERCK SHARP & DOHME·Filed 2010·Granted Jan 8, 2013·1 cites·11 claims
- 1671US6515023B2Thrombin receptor antagonistsMERCK & CO INC·Filed 2001·Granted Feb 4, 2003·6 cites·8 claims
- 1770US6693101B2αv integrin receptor antagonistsMERCK & CO INC·Filed 2001·Granted Feb 17, 2004·4 cites·1 claims
- 1863US2025026759A1Tetrahydroquinazoline derivatives as selective cytotoxic agentsMERCK SHARP & DOHME LLC·Filed 2024·Application pending·0 cites
- 1962US7235580B2Mitotic kinesin inhibitorsMERCK & CO INC·Filed 2003·Granted Jun 26, 2007·2 cites·9 claims
- 2055US2024076291A1Modified isoindolinones as glucosylceramide synthase inhibitorsMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 2152US2023391758A1Modified benzofuran-carboxamides as glucosylceramide synthase inhibitorsMERCK SHARP & DOHME·Filed 2021·Application pending·0 cites
- 2250US2010029736A12-substituted proline bis-amide orexin receptor antagonistsMERCK & CO INC·Filed 2007·Application pending·0 cites
- 2347US7595337B2Mitotic kinesin inhibitorsMERCK & CO INC·Filed 2006·Granted Sep 29, 2009·0 cites·5 claims
- 2447US2009192143A1Substituted diazepan orexin receptor antagonistsCOX CHRISTOPHER D·Filed 2007·Application pending·0 cites
- 2546US2011195957A1Substituted diazepan orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2011·Application pending·0 cites
- 2644US12344595B22-amino-n-phenyl-nicotinamides as NAV1.8 inhibitorsMERCK SHARP & DOHME LLC·Filed 2019·Granted Jul 1, 2025·0 cites·15 claims
- 2744US2009176789A1Diazaspirodecane orexin receptor antagonistsBRESLIN MICHAEL J·Filed 2006·Application pending·0 cites
- 2838US7745639B2Mitotic kinesin inhibitorsMERCK & CO INC·Filed 2003·Granted Jun 29, 2010·0 cites·4 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →